These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

48 related items for PubMed ID: 1725434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Truncated analogues of endothelin and sarafotoxin are selective for the ETB receptor subtype.
    Heyl DL, Cody WL, He JX, Flynn MA, Welch KM, Reynolds EE, Doherty AM.
    Pept Res; 1993; 6(5):238-41. PubMed ID: 8257799
    [Abstract] [Full Text] [Related]

  • 3. Structure-activity studies of the C-terminal region of the endothelins and the sarafotoxins.
    Doherty AM, Cody WL, Leitz NL, DePue PL, Taylor MD, Rapundalo ST, Hingorani GP, Major TC, Panek RL, Taylor DG.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S59-61. PubMed ID: 1725433
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.
    Cody WL, He JX, Reily MD, Haleen SJ, Walker DM, Reyner EL, Stewart BH, Doherty AM.
    J Med Chem; 1997 Jul 04; 40(14):2228-40. PubMed ID: 9216842
    [Abstract] [Full Text] [Related]

  • 6. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
    Gardner A, Westfall TC, Macarthur H.
    J Pharmacol Exp Ther; 2005 Jun 04; 313(3):1109-17. PubMed ID: 15687374
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Importance of secondary structure for endothelin binding and functional activity.
    Panek RL, Major TC, Taylor DG, Hingorani GP, Dunbar JB, Doherty AM, Rapundalo ST.
    Biochem Biophys Res Commun; 1992 Mar 16; 183(2):572-6. PubMed ID: 1550565
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C, Nikiforovich G, Sharma SD, Yang YK, Dickinson C, Hruby VJ, Gantz I.
    J Med Chem; 1997 May 23; 40(11):1738-48. PubMed ID: 9171884
    [Abstract] [Full Text] [Related]

  • 12. Biological and molecular analyses of structurally reduced analogues of endothelin-1.
    Forget MA, Lebel N, Sirois P, Boulanger Y, Fournier A.
    Mol Pharmacol; 1996 Jun 23; 49(6):1071-9. PubMed ID: 8649345
    [Abstract] [Full Text] [Related]

  • 13. A structure-activity study of a C-terminal endothelin analogue.
    Cassano E, Galoppini C, Giusti L, Hamdan M, Macchia M, Mazzoni MR, Menchini E, Pegoraro S, Rovero P.
    Folia Biol (Praha); 1998 Jun 23; 44(1):11-4. PubMed ID: 10730869
    [Abstract] [Full Text] [Related]

  • 14. Ca++ mobilization mediated by endothelin ETA receptor in endothelium of rabbit aortic valve.
    Amano K, Hori M, Ozaki H, Matsuda Y, Karaki H.
    J Pharmacol Exp Ther; 1994 Dec 23; 271(3):1359-64. PubMed ID: 7996447
    [Abstract] [Full Text] [Related]

  • 15. A new endothelin C-terminal analogue IBDP 064 antagonizes endothelin-3-induced cell proliferation.
    Sedo A, Pegoraro S, Rovero P, Revoltella RP.
    Folia Biol (Praha); 1995 Dec 23; 41(2):97-105. PubMed ID: 7656997
    [Abstract] [Full Text] [Related]

  • 16. The receptor binding affinity of monocyclic [Ala3,Xaa11]endothelin-1 analogs correlates with inducible helix length.
    Andersen NH, Harris SM, Lee VG, Liu EC, Moreland S, Hunt JT.
    Bioorg Med Chem; 1995 Feb 23; 3(2):113-24. PubMed ID: 7796045
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic and molecular characterization of the vascular ETA receptor in the venomous snake Bothrops jararaca.
    Borgheresi RA, Leroy JM, Yogi A, DosSantos RA, Breno MC, Tostes RC.
    Exp Biol Med (Maywood); 2006 Jun 23; 231(6):729-35. PubMed ID: 16740989
    [Abstract] [Full Text] [Related]

  • 18. Structure-activity studies of the C-terminal segment of structurally reduced analogues of ET-1.
    Forget MA, Lebel N, Sirois P, Boulanger Y, Battistini B, Fournier A.
    J Cardiovasc Pharmacol; 1995 Jun 23; 26 Suppl 3():S107-10. PubMed ID: 8587333
    [Abstract] [Full Text] [Related]

  • 19. Agonist-dependent inhibition by peptide and nonpeptide endothelin receptor antagonists in the rabbit isolated pulmonary artery.
    Beck GR, Douglas SA, Elliott JD, Ohlstein EH.
    J Cardiovasc Pharmacol; 1995 Jun 23; 26 Suppl 3():S385-8. PubMed ID: 8587422
    [Abstract] [Full Text] [Related]

  • 20. Purification, structural characterization, and myotropic activity of endothelin from trout, Oncorhynchus mykiss.
    Wang Y, Olson KR, Smith MP, Russell MJ, Conlon JM.
    Am J Physiol; 1999 Dec 23; 277(6):R1605-11. PubMed ID: 10600905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.